Head-to-head · Value Score
bmiMD vs yourEra
Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, yourEra a 84. Here's who gives you the honest lower price — and where each one bites back.
bmiMD
#8 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameyourEra
#24 · Grade B+ · Good Value
Est. first month
$199/mo
Save ~85% vs brand-nameThe verdict
bmiMD takes it on Value Score, 89 to 84 — an est. $99/mo first month, with no teaser step-up baked in. yourEra isn't out of it: Shoppers who value seeing the real price upfront and want both molecules plus a longevity menu, and are fine paying a mid-market rate for that transparency.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | bmiMD | yourEra |
|---|---|---|
| Value Score | 89 (A) | 84 (B+) |
| Est. first month | $99/mo | $199/mo |
| Save vs brand-name | ~93% | ~85% |
| Semaglutide | $99/mo | $199/mo |
| Tirzepatide | $139/mo | $299/mo |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
bmiMD
Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.
Why it's a deal
- $99 flat semaglutide and a low $139 tirzepatide
- Available in all 50 states
- Both molecules priced up front
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Thin public track record; no oral or brand-name option
yourEra
A transparent, publicly priced GLP-1 program — both molecules at $199/$299 with no hidden quiz-wall — that's honest and mid-market rather than rock-bottom.
Why it's a deal
- Publishes prices openly on the site — $199 sema / $299 tirz — while many compounders hide pricing behind an intake quiz
- Both compounded semaglutide and tirzepatide, plus a broader menu (NAD+, microdosing, optional coaching/nutritionist/lab bundle)
- Markets a 50-state licensed-clinician network; no insurance required and HSA/FSA accepted
The fine print
- Mid-market pricing — $199/$299 sits above the cheapest compounders (~$99–$150), so it's not the value leader
- Compounded only and not FDA-approved — not equivalent to brand Wegovy/Ozempic/Zepbound, and availability can tighten as brand shortages resolve
- Injectable only — no FDA-approved brand-name lane and no oral option
- Thin independent footprint; the 50-state and efficacy claims are self-reported
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.